HEPARIN SODIUM AND DEXTROSE 5% INJ USP DIN 01913255
Health Canada record
| Active ingredient(s) | HEPARIN SODIUM 4000 UNIT; DEXTROSE 5 G |
|---|---|
| Dosage form | Liquid |
| Route | Intravenous |
| Schedule | ETHICAL |
| Class | Human |
| ATC | B01AB51 HEPARIN, COMBINATIONS |
| Original market date | 31-Dec-1991 |
| Current status date | 01-Feb-2011 |
| Source | Health Canada DPD |
Establishment licence of the holder
Baxter Corporation — licence 100278, currently licensed, last inspection rating C (2026-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing HEPARIN SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00727520 | HEPARIN LEO 100UNIT/ML | LEO PHARMA INC | Solution | HEPARIN SODIUM 100 UNIT | Marketed |
| 00453811 | HEPARIN LEO INJ 1000UNIT/ML | LEO PHARMA INC | Solution | HEPARIN SODIUM 1000 UNIT | Marketed |
| 02209713 | HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ | B. BRAUN MEDICAL INC | Solution | HEPARIN SODIUM 4000 UNIT; DEXTROSE 5 G | Marketed |
| 02209721 | HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ | B. BRAUN MEDICAL INC | Solution | HEPARIN SODIUM 10000 UNIT; DEXTROSE 5 G | Marketed |
| 01990748 | HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION | PFIZER CANADA ULC | Solution | HEPARIN SODIUM 2 UNIT | Marketed |
| 01935941 | HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML | B. BRAUN MEDICAL INC | Solution | HEPARIN SODIUM 5000 UNIT; DEXTROSE 5 G; SODIUM PHOSPHATE DIBASIC 410 MG; CITRIC ACID 93 MG | Marketed |
| 02568144 | HEPARIN SODIUM INJECTION USP | STERIMAX INC | Solution | HEPARIN SODIUM 10000 UNIT | Approved |
| 02382326 | HEPARIN SODIUM INJECTION USP | PFIZER CANADA ULC | Solution | HEPARIN SODIUM 10000 UNIT | Marketed |
| 02456958 | HEPARIN SODIUM INJECTION USP | STERINOVA INC. | Solution | HEPARIN SODIUM 5000 UNIT | Marketed |
| 02548488 | HEPARIN SODIUM INJECTION USP | STERIMAX INC | Solution | HEPARIN SODIUM 5000 UNIT | Marketed |
| 02568136 | HEPARIN SODIUM INJECTION USP | STERIMAX INC | Solution | HEPARIN SODIUM 1000 UNIT | Approved |
| 02303086 | HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | SANDOZ CANADA INCORPORATED | Solution | HEPARIN SODIUM 1000 UNIT | Marketed |
| 02392453 | HEPARIN SODIUM INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | HEPARIN SODIUM 10000 UNIT | Marketed |
| 02482142 | HEPARIN SODIUM INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | HEPARIN SODIUM 10000 UNIT | Approved |
| 02264315 | HEPARIN SODIUM INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | HEPARIN SODIUM 1000 UNIT | Marketed |
| 02264307 | HEPARIN SODIUM INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | HEPARIN SODIUM 10000 UNIT | Marketed |
| 00740497 | HEPALEAN 10,000 USP | SCHERING-PLOUGH CANADA INC | Solution | HEPARIN SODIUM 10000 UNIT | Cancelled Post Market |
| 00740519 | HEPALEAN 1000 USP | SCHERING-PLOUGH CANADA INC | Solution | HEPARIN SODIUM 1000 UNIT | Cancelled Post Market |
| 00740535 | HEPALEAN 25,000 USP | SCHERING-PLOUGH CANADA INC | Solution | HEPARIN SODIUM 25000 UNIT | Cancelled Post Market |
| 02230084 | HEPALEAN-LOK 10 USP | SCHERING-PLOUGH CANADA INC | Solution | HEPARIN SODIUM 10 UNIT | Cancelled Post Market |
| 00740578 | HEPALEAN-LOK 100 USP | SCHERING-PLOUGH CANADA INC | Solution | HEPARIN SODIUM 100 UNIT | Cancelled Post Market |
| 00579718 | HEPARIN LEO INJ 10000UNIT/ML | LEO PHARMA INC | Liquid | HEPARIN SODIUM 10000 UNIT | Cancelled Post Market |
| 00453781 | HEPARIN LEO INJ 25000UNIT/ML | LEO PHARMA INC | Liquid | HEPARIN SODIUM 25000 UNIT | Cancelled Post Market |
| 00640468 | HEPARIN LOCK FLUSH SOLUTION INJ 10UNIT/ML | HOSPIRA HEALTHCARE ULC | Solution | HEPARIN SODIUM 10 UNIT | Cancelled Post Market |
| 00725315 | HEPARIN LOCK FLUSH SOLUTION INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | HEPARIN SODIUM 100 UNIT | Cancelled Post Market |
| 00725323 | HEPARIN LOCK FLUSH SOLUTION INJECTION USP | HOSPIRA HEALTHCARE ULC | Solution | HEPARIN SODIUM 10 UNIT | Cancelled Post Market |
| 02008181 | HEPARIN SODIUM & 5% DEXTROSE INJECTION LIQ | BAXTER CORPORATION | Solution | HEPARIN SODIUM 10000 UNIT; DEXTROSE 5 G | Cancelled Post Market |
| 01900757 | HEPARIN SODIUM & DEXTROSE 5% IN VIAFLEX LIQ | BAXTER CORPORATION | Solution | HEPARIN SODIUM 5000 UNIT; DEXTROSE 5 G | Cancelled Post Market |
| 00894648 | HEPARIN SODIUM 20000UNIT/500ML IN DEXT 5% INJ | HOSPIRA HEALTHCARE ULC | Solution | HEPARIN SODIUM 40 UNIT | Cancelled Post Market |
| 00894605 | HEPARIN SODIUM 25000UNIT/500ML IN 5% DEXTR INJ | HOSPIRA HEALTHCARE ULC | Solution | HEPARIN SODIUM 50 UNIT | Cancelled Post Market |
| 00622354 | HEPARIN SODIUM 5000UNIT/500ML IN SODIUM CHLORIDE 0.9% | HOSPIRA HEALTHCARE ULC | Solution | HEPARIN SODIUM 10 UNIT | Cancelled Post Market |
| 01935933 | HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION | B. BRAUN MEDICAL INC | Solution | HEPARIN SODIUM 200 UNIT; SODIUM CHLORIDE 900 MG; SODIUM PHOSPHATE DIBASIC 430 MG; CITRIC ACID 37 MG | Dormant |
| 02382318 | HEPARIN SODIUM INJECTION USP | PFIZER CANADA ULC | Solution | HEPARIN SODIUM 5000 UNIT | Cancelled Pre Market |
| 02382334 | HEPARIN SODIUM INJECTION USP | PFIZER CANADA ULC | Solution | HEPARIN SODIUM 5000 UNIT | Cancelled Post Market |
| 02382288 | HEPARIN SODIUM INJECTION USP | PFIZER CANADA ULC | Solution | HEPARIN SODIUM 1000 UNIT | Cancelled Pre Market |
| 02382296 | HEPARIN SODIUM INJECTION USP | PFIZER CANADA ULC | Solution | HEPARIN SODIUM 1000 UNIT | Cancelled Post Market |
| 02303094 | HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) | SANDOZ CANADA INCORPORATED | Solution | HEPARIN SODIUM 10000 UNIT | Dormant |
| 02303108 | HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | SANDOZ CANADA INCORPORATED | Solution | HEPARIN SODIUM 10000 UNIT | Dormant |
International API supply for HEPARIN SODIUM
3 valid EDQM Certificates of Suitability from 3 holders. 26 active FDA Drug Master Files.
Request a quote for HEPARIN SODIUM AND DEXTROSE 5% INJ USP